BI 1493-0002 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A double-blind, randomised, placebo-controlled, parallel group, Phase IIa trial to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BI 765423 administered intravenously with or without standard of care in patients with idiopathic pulmonary fibrosis (IPF)
BI 1493-0002
Principal Investigator
Lake D. Morrison, MD
Pulmonologist
Protocol Number
IRB:
PRO00119034
NCT:
NCT07036523
Phase
Phase II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment